Company
AstraZeneca
AstraZeneca is a global pharmaceutical company that researches, develops, and commercializes prescription medicines across oncology, cardiovascular, respiratory, infectious disease, and rare disease therapy areas. The company focuses on transforming patient outcomes through innovative treatments and aims to deliver 20 new medicines by 2030. With $58.7 billion in annual revenue, AstraZeneca operates research centers globally and invests significantly in science and AI-driven drug development.
AstraZeneca is a publicly traded company operating in the pharmaceutical industry sector, based in the United Kingdom. It trades on the New York Stock Exchange under the ticker AZN. Leadership tracked by CEOInsider includes Pascal Soriot (CEO).
Leadership
Current
